Table 4.
Meta-regression analysis of variables predicting serum and plasma levels of IL-4.
| Factors | Sample | Coefficient | Standard error | 95% CI | Adjusted R2 | P |
|---|---|---|---|---|---|---|
| Ethnicity | Serum | 0.186 | 0.566 | −0.966 to 1.339 | −0.029 | .774 |
| Plasma | −0.195 | 0.548 | −1.400 to 1.011 | −0.086 | .729 | |
| Study design | Serum | −0.662 | 0.428 | −1.533 to 0.209 | 0.041 | .123 |
| Plasma | 0.217 | 0.615 | −1.135 to 1.570 | −0.087 | .73 | |
| Assay approach | Serum | 0.609 | 1.067 | −1.564 to 2.783 | −0.023 | .572 |
| Plasma | −0.84 | 1.386 | −3.890 to 2.211 | −0.061 | .557 | |
| Infection site | Serum | −0.515 | 0.968 | −2.486 to 1.456 | −0.025 | .598 |
| Plasma | −0.969 | 1.374 | −3.993 to 2.055 | −0.048 | .495 | |
| Drug resistance | Serum | −0.141 | 0.766 | −1.702 to 1.420 | −0.033 | .855 |
| Plasma | NA | NA | NA | NA | NA | |
| Infection status | Serum | −1.54 | 0.809 | −3.187 to 0.107 | 0.078 | .066 |
| Plasma | −1.225 | 1.139 | −3.731 to 1.281 | 0.015 | .305 |
CI = confidence interval, IL-4 = interleukin-4, NA = not applicable.